179.48MMarket Cap-462P/E (TTM)
1.140High0.695Low123.71MVolume0.713Open0.672Pre Close114.76MTurnover72.36%Turnover RatioLossP/E (Static)207.51MShares1.48052wk High3.17P/B147.86MFloat Cap0.29152wk Low--Dividend TTM170.95MShs Float51.375Historical High--Div YieldTTM66.22%Amplitude0.291Historical Low0.927Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
please fly to moon, make my day.
This treatment for patients with hemophilia A appears to have the efficacy and safety metrics in place to warrant a potential approval.
Notably, Sangamo’s candidate is being developed alongside $Pfizer(PFE.US)$ , adding a layer of clout to the R&D behind the prospective treatment.
woke up at 3.55am just to ensure no more position.. fall asleep earlier.. small profit still a profit.. not a fan of holding stock.need peace…
No comment yet